La catena delle opzioni mostra i dati chiave delle opzioni azionarie di EZCORP a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per EZCORP..

EZCORP (NASDAQ:EZPW) Azioni, Catena delle Opzioni

EZCORP INC-CL A

EZCORP

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

wall street chart shutter2

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

EZPW

HRTG

Titoli del settore finanziario a rischio correzione nel breve termine. Le strategie per proteggere il portafoglio e massimizzare i profitti.

3 azioni finanziarie che potrebbero crollare ad aprile

EZCORP, Inc. - Class A Non-Voting Common Stock

EZCORP Inc

<a target="_blank" href="https://www.benzinga.com/fintech" rel="noreferrer noopener">Fintech mortgage lender</a> Beeline Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNE#NASDAQ">BLNE</a>) announced Wednesday the upcoming launch of a new home equity access product that allows homeowners to convert a portion of their home equity into immediate cash without incurring debt or monthly payments.
Beeline has partnered with a company ("RealCo") co-owned by Beeline's principal shareholder and CEO.
RealCo will issue stablecoins to access capital to purchase equity from homeowners seeking liquidity.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/45064810/exclusive-beeline-breaks-1-billion-barrier-bets-big-on-ai-and-short-term-rental-surge" rel="noreferrer noopener">Beeline Breaks $1 Billion Barrier, Bets Big On AI And Short-Term Rental Surge</a>
RealCo is engaging with Beeline, which will source consumers and provide services. Beeline Title will provide title and escrow services.
The company said this product will be funded through a stablecoin-backed model, offering homeowners a fast and flexible alternative to traditional refinancing or HELOCs.
The hard launch is likely for late July, with beta transactions beginning in June.
The coins will be backed by ownership through a fractional deed on the property. RealCo will acquire minority ownership in homes (up to 49%) as a nominee for the funders who will receive the stablecoins. Homeowners selling equity can opt to receive RealCo-issued stablecoins or U.S. dollars.
Unlike conventional lending products, this is not a loan transaction tied to interest rates or a buy-back obligation, allowing Beeline to generate consistent revenue in any rate environment.
The company expects it would drive faster percentage-based revenue growth than traditional mortgage lenders, and with the fees, it expects to be well-positioned to reach operational profitability beginning in the fourth quarter of 2025.
RealCo will initially launch in approximately ten thousand U.S. zip codes and only enter into equity purchases on homes valued at $1 million.
Nick Liuzza, CEO of Beeline Holdings, said that provided there's equity in the home, RealCo will mint coins at closing, which may then be converted into U.S. dollars.
The stablecoin mechanism becomes the catalyst for funding, and it is secured by property recorded in 1:1 in the blockchain and in the public record, he said.
Participating homeowners will receive cash at closing and will not be required to repay the funds until the property is sold. Upon sale, RealCo, as nominee for the token holders, will receive its pro rata percentage of the net proceeds.
Beeline's existing product suite includes conventional mortgage offerings and a range of non-QM loan programs, many of which are optimized for 1099 earners, self-employed borrowers, and younger homeowners. The company emphasized that this new product is an addition, not a pivot, from its core model.
The product will likely benefit individuals who do not qualify for traditional cash-out refinancing or HELOCs but have meaningful equity. Beeline anticipates additional use cases to emerge as the product rolls out to a broader audience in the months ahead.
Key U.S. home equity lending players included Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), JPMorgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), LendingTree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>), and US Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>).
Price Action: At the last check on Wednesday, BLNE shares were trading higher by 11.7% at $0.9880 premarket.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45748544/walmart-leverages-automation-and-ai-to-cut-costs-and-grow-paving-the-way-for-other-retailers-report" target="_blank" rel="noreferrer noopener">Walmart Leverages Automation And AI To Cut Costs And Grow, Paving The Way For Other Retailers: Report</a></li>
</ul>
Photo via Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Market-Moving Exclusives

Exclusives

Tech

ALLY

BLNE

CITZ

DGLY

GDOT

TREE

EXCLUSIVE: Beeline Launches Stablecoin-Backed Home Equity Product, Targets Profitability By Late 2025

Dear Members of the Board and Management,
As long-term shareholders of EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>), and owners of over 1.5% of the company's outstanding shares, we write to urge the Board to immediately authorize and begin executing on a $100 million share repurchase program.
The company raised $300 million in part to settle the convertible notes in cash. Instead, management opted to settle entirely in equity in Q4 2024, assuming the convertible note would remain out of the money. As the stock moved higher, this miscalculation resulted in unexpected and avoidable dilution—despite the company having both the intent and resources to avoid it. This misstep should now be addressed through a meaningful and accretive share repurchase.
A buyback program is the clearest way to re-establish credibility—not only with shareholders, but also with employees (many of whom are stakeholders), analysts, and the broader investment community, all of whom are increasingly questioning the company's capital allocation discipline.
We previously urged the company in December 2022 to begin executing on a $200 million buyback over five years when the stock was trading at just $8.00 per share1. At that valuation, aggressive repurchases would have been extremely accretive. Instead, EZCORP has repurchased only $33 million in stock over 2.5 years—missing a clear, high-return opportunity. We now face a similar setup—but with stronger earnings momentum, a fortified balance sheet, and even more excess cash—much of which was explicitly earmarked for shareholder value preservation. EZCORP cannot afford to make the same mistake twice.
Today, EZPW trades at approximately 4.5x LTM Adj. EBITDA, adjusting for its valuable minority stakes in Simple Management and Cash Converters International2. By contrast, FirstCash (FCFS) trades at over 12x EBITDA—despite EZCORP's more focused strategy and operational momentum. The disparity is glaring and reflects a serious credibility gap with the market—one that can only be resolved through meaningful, shareholder-aligned action.

Buybacks

Management

Kanen Wealth Management 1.5% Shareholders Of EZCORP Urge The Board To Immediately Authorize And Begin Executing On A $100M Share Repurchase Program

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">EZCORP Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>)</h3>
<ul class="wp-block-list">
<li>On April 28, EZCORP posted downbeat quarterly sales. Lachie Given, Chief Executive Officer, said, &#8220;Our team delivered another impressive quarter of operational and financial performance, highlighted by record Q2 PLO, which drove strong growth in revenue and pawn service charges. Persistent inflation and economic pressure continue to impact value-conscious consumers who are increasingly turning to us for short-term cash and secondhand goods. Our strengthened operating model and best-in-class customer service also fueled the bottom line, driving a material increase in adjusted EBITDA to $45.1 million, up 23%.&#8221; The company's stock fell around 18% over the past month and has a 52-week low of $9.66.</li>
<li>RSI Value: 26.8</li>
<li>EZPW Price Action: Shares of EZCORP fell 2.2% to close at $13.14 on Thursday.</li>
<li>Edge Stock Ratings: 87.01 Momentum score with Value at 85.88. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/EZPW"><img loading="lazy" decoding="async" width="497" height="197" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041358/image-299.png" alt="" class="wp-image-925549" style="width:389px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041358/image-299.png 497w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041358/image-299-300x119.png 300w" sizes="(max-width: 497px) 100vw, 497px" /></a></figure>
<h3 class="wp-block-heading">Compass Diversified Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CODI#NYSE">CODI</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On April 1, Compass Diversified reported the appointment of Matthew Blake as CEO of Arnold Magnetics. &#8220;On behalf of Compass and Arnold, I want to extend our sincere gratitude to Dan for his dedication and service in building Arnold into the industry leader it is today,&#8221; said Elias Sabo, CEO of CODI. &#8220;Under his leadership, Arnold has strengthened its position as a leading solutions provider, successfully navigated the COVID-19 pandemic and oversaw the company&#8217;s recent plant relocation. We wish him all the best. I also want to welcome Matt to both Arnold and Compass Diversified. With leadership experience spanning multiple facets of industrial manufacturing, I believe he is the ideal choice to lead Arnold in its next phase of growth.&#8221; The company's stock fell around 56% over the past month and<a href="https://www.benzinga.com/quote/CODI"> has a 52-week low</a> of $6.05.</li>
<li>RSI Value: 22.4</li>
<li>CODI Price Action: Shares of Compass Diversified gained 1.5% to close at $7.36 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523">CODI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="931" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041508/image-300.png" alt="" class="wp-image-925550" style="width:617px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041508/image-300.png 931w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041508/image-300-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041508/image-300-768x694.png 768w" sizes="(max-width: 931px) 100vw, 931px" /></a></figure>
<h3 class="wp-block-heading">Top KingWin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAI#NASDAQ">WAI</a>)</h3>
<ul class="wp-block-list">
<li>On May 1, Top KingWin announced a 1-for-25 reverse share split. The company's stock fell around 54% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/WAI"> low of $1.75</a>.</li>
<li>RSI Value: 28.3</li>
<li>WAI Ltd Price Action: Shares of Top KingWin fell 5.8% to close at $1.80 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523">WAI shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="867" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041608/image-301.png" alt="" class="wp-image-925551" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041608/image-301.png 867w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041608/image-301-300x286.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23041608/image-301-768x733.png 768w" sizes="(max-width: 867px) 100vw, 867px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45562909/top-2-financial-stocks-that-may-keep-you-up-at-night-in-may">Top 2 Financial Stocks That May Keep You Up At Night In May</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

CODI

Top 3 Financial Stocks That May Rocket Higher This Month

Stephens &amp; Co. analyst Kyle Joseph reiterates EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Equal-Weight and maintains $17 price target.

Price Target

Reiteration

Analyst Ratings

Stephens & Co. Reiterates Equal-Weight on EZCORP, Maintains $17 Price Target

Analysts' ratings for EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated EZCORP and provided 12-month price targets. The average target is $18.88, accompanied by a high estimate of $24.00 and a low estimate of $13.50. Observing a downward trend, the current average is 1.51% lower than the prior average price target of $19.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1746532842_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of EZCORP by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian McNamara</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Craig Irwin</td>
<td>Roth MKM</td>
<td>Announces</td>
<td>Buy</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian McNamara</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Kyle Joseph</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$13.50</td>
<td>$13.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to EZCORP. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of EZCORP compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for EZCORP's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into EZCORP's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EZPW/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EZCORP analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About EZCORP</h2>
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
<h3>Key Indicators: EZCORP's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: EZCORP's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 7.24%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: EZCORP's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 8.29%, the company may face hurdles in effective cost management.
Return on Equity (ROE): EZCORP's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.03%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): EZCORP's ROA stands out, surpassing industry averages. With an impressive ROA of 1.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: EZCORP's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For EZCORP's Future

Canaccord Genuity analyst Brian McNamara maintains EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy and lowers the price target from $25 to $24.

Canaccord Genuity Maintains Buy on EZCORP, Lowers Price Target to $24

EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) (the "Company"), a leading provider of pawn transactions in the United States and Latin America, announced today the retirement of its $103.4 million aggregate principal amount outstanding of 2.375% Convertible Senior Notes Due 2025 (the "2025 Notes"). The 2025 Notes were issued in 2018 with a maturity date of May 1, 2025.
In connection with the Company's election of physical settlement made in October 2024, holders had the right to convert their 2025 Notes into 62.8931 shares of EZCORP Class A Common Stock per $1,000 principal amount (equivalent to the conversion price of $15.90&nbsp;per share) through April 30, 2025.&nbsp;Holders converted approximately $97.0 million in principal amount of the 2025 Notes into approximately 6.1 million shares of EZCORP Class A Common Stock.&nbsp;The Company repaid the remaining principal balance of the notes in cash of approximately $6.4 million, together with payments of interest and cash in lieu of fractional shares of $1.2 million.

EZCORP Announces The Retirement Of Its $103.4M Aggregate Principal Amount Outstanding Of 2.375% Convertible Senior Notes Due 2025

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31 by 9.68 percent. This is a 21.43 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $306.32 million which missed the analyst consensus estimate of $310.35 million by 1.30 percent. This is a 7.24 percent increase over sales of $285.64 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

EZCORP Q2 Adj. EPS $0.34 Beats $0.31 Estimate, Sales $306.32M Miss $310.35M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Guardforce AI Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFAI#NASDAQ">GFAI</a>) is projected to report earnings for its Fiscal Year 2024. 
• Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) is expected to report earnings for its second quarter. 
• Kandi Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is estimated to report earnings for its fourth quarter. 
• SuperCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) is projected to report quarterly loss at $0.46 per share on revenue of $6.48 million. 
• Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) is expected to report quarterly earnings at $0.24 per share on revenue of $9.86 million. 
• Toyo Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOYO#NASDAQ">TOYO</a>) is estimated to report earnings for its Fiscal Year 2024. 
• InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $77.57 million. 
• BankUnited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKU#NYSE">BKU</a>) is likely to report quarterly earnings at $0.76 per share on revenue of $263.57 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is projected to report quarterly earnings at $0.51 per share on revenue of $556.31 million. 
• Roper Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) is projected to report quarterly earnings at $4.75 per share on revenue of $1.89 billion. 
• Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is estimated to report quarterly earnings at $0.96 per share on revenue of $662.30 million. 
• Opera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) is expected to report quarterly earnings at $0.24 per share on revenue of $132.48 million. 
• Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) is likely to report quarterly loss at $0.37 per share on revenue of $14.37 million. 
• Rithm Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPT#NYSE">RPT</a>) is projected to report earnings for its first quarter. 
• Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) is estimated to report earnings for its first quarter. 
• Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) is likely to report quarterly earnings at $4.04 per share on revenue of $1.12 billion. 
• Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $16.16 million. 
• Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $27.99 million. 
• Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $3.85 billion. 
<h3>Companies Reporting After The Bell</h3>
• Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $169.00 million. 
• Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) is projected to report quarterly loss at $0.25 per share on revenue of $116.40 million. 
• SunCar Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) is projected to report earnings for its Fiscal Year 2024. 
• EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is expected to report quarterly earnings at $0.30 per share on revenue of $306.17 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is projected to report quarterly loss at $0.63 per share on revenue of $288.13 million. 
• Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) is likely to report quarterly earnings at $1.38 per share on revenue of $1.97 billion. 
• Firstsun Capital Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSUN#NASDAQ">FSUN</a>) is expected to report earnings for its first quarter. 
• CVR Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) is estimated to report quarterly loss at $0.75 per share on revenue of $1.65 billion. 
• Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $1.02 billion. 
• Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $2.37 billion. 
• Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $127.51 million. 
• Financial Institutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISI#NASDAQ">FISI</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $56.32 million. 
• Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is likely to report quarterly earnings at $1.68 per share on revenue of $6.12 billion. 
• Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is estimated to report earnings for its first quarter. 
• Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $546.93 million. 
• Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $276.83 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $162.83 million. 
• PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $243.68 million. 
• Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) is likely to report quarterly loss at $0.52 per share on revenue of $2.71 billion. 
• F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) is projected to report quarterly earnings at $3.22 per share on revenue of $703.63 million. 
• NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is expected to report quarterly earnings at $2.60 per share on revenue of $2.83 billion. 
• Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is estimated to report quarterly earnings at $1.50 per share on revenue of $1.24 billion. 
• Gerdau (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGB#NYSE">GGB</a>) is estimated to report earnings for its first quarter. 
• Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is expected to report quarterly earnings at $2.29 per share on revenue of $758.46 million. 
• Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $7.31 billion. 
• Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $1.41 billion. 
• SJW Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NASDAQ">SJW</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $160.54 million. 
• Two Harbors Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $-28 million. 
• Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $34.94 million. 
• Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $7.58 million. 
• Solaris Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEI#NYSE">SEI</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $119.20 million. 
• SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) is expected to report quarterly earnings at $2.32 per share on revenue of $661.98 million. 
• CVR Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAN#NYSE">UAN</a>) is expected to report earnings for its first quarter. 
• CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $975.80 million. 
• UFP Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) is projected to report quarterly earnings at $1.57 per share on revenue of $1.61 billion. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is projected to report quarterly earnings at $1.46 per share on revenue of $838.72 million. 
• Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is projected to report quarterly earnings at $1.77 per share on revenue of $544.94 million. 
• Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $680.54 million. 
• Transocean (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) is projected to report quarterly loss at $0.10 per share on revenue of $884.92 million. 
• Piedmont Office Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $141.29 million. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $334.61 million. 
• Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is expected to report quarterly earnings at $4.38 per share on revenue of $4.16 billion. 
• COPT Defense Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDP#NYSE">CDP</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $185.78 million. 
• Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) is projected to report quarterly earnings at $1.23 per share on revenue of $2.82 billion. 
• Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $863.31 million. 
• Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $1.28 billion. 
• NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $2.10 billion. 
• Northwest Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWBI#NASDAQ">NWBI</a>) is estimated to report quarterly earnings at $0.24 per share on revenue of $142.16 million. 
• RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $28.98 million. 
• Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $53.04 million. 
• Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $44.21 million. 
• Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is likely to report earnings for its first quarter. 
• Alerus Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $66.19 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $561.40 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABCB

ALRS

AMKR

ARLP

BEDU

BMRC

BYON

CDNS

CINF

EFSC

FBRT

FFIV

FISI

Fomento Economico Mexicano S.A.B. De C.V.

FSBC

FSUN

GFAI

HLIT

INMD

KFRC

KNDI

MBIN

NTST

NWBI

NXPI

OPRA

PERF

PROV

RMBS

RVTY

SANM

SBAC

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SEVN

SILC

SPCB

TOYO

UCTT

UFPI

WELL

Earnings Scheduled For April 28, 2025

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) will release its quarterly earnings report on Monday, 2025-04-28. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate EZCORP to report an earnings per share (EPS) of $0.30.
The market awaits EZCORP's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.05, leading to a 0.98% increase in the share price the following trading session.
Here's a look at EZCORP's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.37</td>
<td>0.26</td>
<td>0.21</td>
<td>0.25</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.42</td>
<td>0.26</td>
<td>0.23</td>
<td>0.28</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>1.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745607691_0.png" alt="eps graph" />
<h3>EZCORP Share Price Analysis</h3>
Shares of EZCORP were trading at $16.38 as of April 24. Over the last 52-week period, shares are up 45.97%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on EZCORP</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding EZCORP.
With 3 analyst ratings, EZCORP has a consensus rating of Buy. The average one-year price target is $17.17, indicating a potential 4.82% upside.
<h3>Comparing Ratings with Competitors</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Encore Capital Gr and Dave, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Encore Capital Gr, with an average 1-year price target of $57.0, suggesting a potential 247.99% upside.</li>
<li>Analysts currently favor an Buy trajectory for Dave, with an average 1-year price target of $124.5, suggesting a potential 660.07% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Encore Capital Gr and Dave, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>EZCORP</td>
<td>Buy</td>
<td>6.73%</td>
<td>$185.40M</td>
<td>3.81%</td>
</tr>
<tr>
<td>Encore Capital Gr</td>
<td>Buy</td>
<td>-4.24%</td>
<td>$83.73M</td>
<td>-24.82%</td>
</tr>
<tr>
<td>Dave</td>
<td>Buy</td>
<td>37.91%</td>
<td>$94.56M</td>
<td>9.92%</td>
</tr>
</tbody>
</table>

Key Takeaway:
EZCORP is positioned at the top for Revenue Growth among its peers, showing a strong growth rate. In terms of Gross Profit, EZCORP is also leading the group with the highest figure. However, EZCORP's Return on Equity is in the middle compared to its peers, indicating a moderate performance in this aspect.
<h3>Get to Know EZCORP Better</h3>
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
<h3>EZCORP: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: EZCORP's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 6.73%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: EZCORP's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 9.69%, the company may face hurdles in effective cost management.
Return on Equity (ROE): EZCORP's ROE stands out, surpassing industry averages. With an impressive ROE of 3.81%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.07%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.69, EZCORP adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/EZPW/earnings">To track all earnings releases for EZCORP visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: EZCORP's Earnings

In the current session, the stock is trading at $15.84, after a 0.37% spike. Over the past month, EZCORP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) stock increased by 16.64%, and in the past year, by 43.67%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1743786033_0.png" alt="Past Year Chart" />

<h3>Comparing EZCORP P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 18.15 in the Consumer Finance industry, EZCORP Inc. has a lower P/E ratio of 13.84. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743786033_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for EZCORP

As of April 4, 2025, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Heritage Insurance Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>)</h3>
<ul>
<li>On March 11, Heritage Insurance posted better-than-expected quarterly earnings. &#8220;The year 2024 was marked by numerous destructive hurricanes affecting communities across the Southeastern United States and in 2025, we&#8217;ve seen devastating wildfires affect residents of California,&#8221; said Ernie Garateix, Heritage CEO. The company's stock gained around 35% over the past month and has a 52-week high of $16.90.</li>
<li>RSI Value: 75.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>HRTG Price Action: Shares of Heritage Insurance gained 0.6% to close at $15.62 on Thursday.</li>
<li>Edge Stock Ratings: 94.40 Momentum score with Value at 91.39. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/HRTG"><img loading="lazy" decoding="async" width="432" height="178" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42.png" alt="" class="wp-image-857066" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42.png 432w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42-300x124.png 300w" sizes="(max-width: 432px) 100vw, 432px" /></a></figure>
<h3 class="wp-block-heading">CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>)</h3>
<ul>
<li>On April 2, CME Group reported that average daily volume rose 13% year-over-year in the first quarter. The company's stock gained around 7% over the past month and <a href="https://www.benzinga.com/quote/CME">has a 52-week high</a> of $271.22.</li>
<li>RSI Value: 71.4</li>
<li>CME Price Action: Shares of CME gained 2.2% to close at $268.36 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">EZCORP Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>)</h3>
<ul>
<li>On March 28, EZCORP announced the closing of private offering of $300,000,000 of senior notes due 2032. The company's stock gained around 19% over the past month and has a<a href="https://www.benzinga.com/quote/EZPW"> 52-week high</a> of $16.35.</li>
<li>RSI Value: 76.5</li>
<li>EZPW Price Action: Shares of EZCORP gained 3% to close at $15.78 on Thursday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Top 3 Financial Stocks That May Fall Off A Cliff In April

Reported Earlier, EZCORP Announces $300M Senior Notes Offering At 7.375% Interest, Maturing 2032, With Proceeds To Repay Convertible Debt

EZCORP Terminates Acquisition Agreement With Presta Dinero For Purchase Of 53 Stores In Mexico

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Lake Street analyst Frank Takkinen initiated coverage on Axogen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) with a Buy rating and announced a price target of $30. Axogen shares closed at $17.25 on Friday. <a href="https://www.benzinga.com/quote/AXGN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum analyst John Wilkin initiated coverage on Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) with a Buy rating and announced a price target of $8. Personalis shares closed at $3.63 on Friday. <a href="https://www.benzinga.com/quote/PSNL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Andrew Brackmann initiated coverage on Butterfly Network, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) with an Outperform rating. Butterfly Network shares closed at $2.68 on Friday. <a href="https://www.benzinga.com/quote/BFLY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM analyst Craig Irwin initiated coverage on EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy rating and announced a price target of $16. EZCORP shares closed at $13.45 on Friday. <a href="https://www.benzinga.com/quote/EZPW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Michael Yee initiated coverage on Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) with a Buy rating and announced a price target of $135. Blueprint Medicines shares closed at $89.58 on Friday. <a href="https://www.benzinga.com/quote/BPMC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BPMC stock? Here&#8217;s what analysts think: 
<ul>
<li><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Photo: Bigc Studio/Shutterstock.com

Initiation

AXGN

BFLY

BPMC

PSNL

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Roth MKM analyst Craig Irwin initiates coverage on EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy rating and announces Price Target of $16.

Roth MKM Initiates Coverage On EZCORP with Buy Rating, Announces Price Target of $16

A new SEC filing reveals that Srivatsa Zena Arnold, Board Member at EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>), made a notable insider purchase on March 14,.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000876523/000177703625000002//Archives/edgar/data/876523/000177703625000002/0001777036-25-000002-index.htm">U.S. Securities and Exchange Commission</a> on Friday showed that Arnold purchased 12,725 shares of EZCORP. The total transaction amounted to $170,006. 
During Friday's morning session, EZCORP shares down by 0.0%, currently priced at $13.14.
<h3>Discovering EZCORP: A Closer Look</h3>
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
<h3>A Deep Dive into EZCORP's Financials</h3>
Revenue Growth: EZCORP's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 6.73%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 57.91%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): EZCORP's EPS reflects a decline, falling below the industry average with a current EPS of 0.57.
</li>
</ul>
Debt Management: EZCORP's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.69.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 11.53 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 0.93, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): EZCORP's EV/EBITDA ratio at 6.74 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Important Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000876523">Check Out The Full List Of EZCORP's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Move: Srivatsa Zena Arnold Invests $170K In EZCORP Stock

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Barclays BCS: This major global banking and financial services company with more than 325 years of expertise in banking, and operating through an international network in nearly 40 countries and regions in Europe, the U.S., Africa and Asia, the company provides a wide range of financial services to individuals, corporations and institutions, has seen the Zacks Consensus Estimate for its current year earnings increasing 29% over the last 60 days.
<div class="chart_embed">
<h3>Barclays PLC Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/BCS/price-consensus-chart?icid=chart-BCS-price-consensus-chart"><img alt="Barclays PLC Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/a2/1740650708.png" style="height:283px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/BCS/price-consensus-chart?icid=chart-BCS-price-consensus-chart">Barclays PLC price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/BCS?icid=chart-BCS-price-consensus-chart">Barclays PLC Quote</a>
</div>
CareDx CDNA: This commercial stage company which develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients, has seen the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.
<div class="chart_embed">
<h3>CareDx, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/CDNA/price-consensus-chart?icid=chart-CDNA-price-consensus-chart"><img alt="CareDx, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/a2/1740650708.png" style="height:282px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/CDNA/price-consensus-chart?icid=chart-CDNA-price-consensus-chart">CareDx, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/CDNA?icid=chart-CDNA-price-consensus-chart">CareDx, Inc. Quote</a>
</div>
The Progressive PGR: This company which is one of the major auto insurers in the country, has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 day.
<div class="chart_embed">
<h3>The Progressive Corporation Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PGR/price-consensus-chart?icid=chart-PGR-price-consensus-chart"><img alt="The Progressive Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/df/1740650710.png" style="height:278px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PGR/price-consensus-chart?icid=chart-PGR-price-consensus-chart">The Progressive Corporation price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PGR?icid=chart-PGR-price-consensus-chart">The Progressive Corporation Quote</a>
</div>
EZCORP EZPW: This company which is engaged in establishing, acquiring, and operating pawnshops which function as convenient sources of consumer credit and as value-oriented specialty retailers of primarily previously owned merchandise, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
<div class="chart_embed">
<h3>EZCORP, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart"><img alt="EZCORP, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/b7/1740650711.png" style="height:283px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. Quote</a>
</div>
EverQuote EVER: This company which operates an online marketplace for consumers shopping for auto, home and renters and life insurance, has seen the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
<div class="chart_embed">
<h3>EverQuote, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EVER/price-consensus-chart?icid=chart-EVER-price-consensus-chart"><img alt="EverQuote, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/ce/1740650716.png" style="height:282px; width:610px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EVER/price-consensus-chart?icid=chart-EVER-price-consensus-chart">EverQuote, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EVER?icid=chart-EVER-price-consensus-chart">EverQuote, Inc. Quote</a>
</div>
&nbsp;
You can see&nbsp;<a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">the complete list of today&#39;s Zacks #1 Rank (Strong Buy) stocks here</a>.
&nbsp;
<h2>5 Stocks Set to Double</h2>
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/4e87?add=1726&amp;adid=SYND_BENZ_ZU_5S2DREPORT_ZACKS1RANKADDITIONS_02272025_2420915&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915" style="font-weight:bold">Today, See These 5 Potential Home Runs &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_2420915&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=BCS&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_BCS&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">Barclays PLC (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/bcs#NYSE">BCS</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PGR&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_PGR&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">The Progressive Corporation (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/pgr#NYSE">PGR</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EZPW&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_EZPW&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">EZCORP, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EVER&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_EVER&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">EverQuote, Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/ever#NYSE">EVER</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CDNA&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_2420915_CDNA&amp;cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">CareDx, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/cdna#NASDAQ">CDNA</a>): Free Stock Analysis Report
<a href="https://www.zacks.com/commentary/2420915/new-strong-buy-stocks-for-february-27th?cid=CS-BENZ-FT-zacks_1_rank_additions-2420915">This article originally published on Zacks Investment Research (zacks.com).</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Equities

CDNA

EVER

New Strong Buy Stocks For February 27th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 11th:
OMV Aktiengesellschaft OMVKY: This energy and chemicals company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
<div class="chart_embed">
<h3>OMV AG Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/OMVKY/price-consensus-chart?icid=chart-OMVKY-price-consensus-chart"><img alt="OMV AG Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f0/1739262717.png" style="height:264px; width:527px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/OMVKY/price-consensus-chart?icid=chart-OMVKY-price-consensus-chart">OMV AG price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/OMVKY?icid=chart-OMVKY-price-consensus-chart">OMV AG Quote</a>
</div>
OMV has a price-to-earnings ratio (P/E) of 5.96, compared with 7.30 for the industry. The company possesses a <a href="https://www.zacks.com/style-scores-education/">Value Score</a>&nbsp; of A.
<div class="chart_embed">
<h3>OMV AG PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/OMVKY/fundamental/pe-ratio-ttm?icid=chart-OMVKY-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/c9/1739262943.png&quot; title=&quot;&quot; width=&quot;493&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/OMVKY/fundamental/pe-ratio-ttm?icid=chart-OMVKY-fundamental/pe-ratio-ttm">OMV AG pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/OMVKY?icid=chart-OMVKY-fundamental/pe-ratio-ttm">OMV AG Quote</a>
</div>
Pacira BioSciences, Inc. PCRX: This non-opioid pain management and regenerative health solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 21% over the last 60 days.
<div class="chart_embed">
<h3>Pacira BioSciences, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PCRX/price-consensus-chart?icid=chart-PCRX-price-consensus-chart"><img alt="Pacira BioSciences, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/18/1739262729.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PCRX/price-consensus-chart?icid=chart-PCRX-price-consensus-chart">Pacira BioSciences, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PCRX?icid=chart-PCRX-price-consensus-chart">Pacira BioSciences, Inc. Quote</a>
</div>
Pacira has a price-to-earnings ratio (P/E) of 7.69, compared with 24.45 for the S&amp;P 500. The company possesses a Value Score of A.
<div class="chart_embed">
<h3>Pacira BioSciences, Inc. PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PCRX/fundamental/pe-ratio-ttm?icid=chart-PCRX-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/35/1739262962.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PCRX/fundamental/pe-ratio-ttm?icid=chart-PCRX-fundamental/pe-ratio-ttm">Pacira BioSciences, Inc. pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PCRX?icid=chart-PCRX-fundamental/pe-ratio-ttm">Pacira BioSciences, Inc. Quote</a>
</div>
EZCORP, Inc. EZPW: This pawn services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
<div class="chart_embed">
<h3>EZCORP, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart"><img alt="EZCORP, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f4/1739262742.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. Quote</a>
</div>
Ezcorp has a price-to-earnings ratio (P/E) of 10.33, compared with 15.30 for the industry. The company possesses a Value Score of A.
<div class="chart_embed">
<h3>EZCORP, Inc. PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/fundamental/pe-ratio-ttm?icid=chart-EZPW-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;251&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/b8/1739262981.png&quot; title=&quot;&quot; width=&quot;532&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/EZPW/fundamental/pe-ratio-ttm?icid=chart-EZPW-fundamental/pe-ratio-ttm">EZCORP, Inc. pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-fundamental/pe-ratio-ttm">EZCORP, Inc. Quote</a>
</div>
&nbsp;
See <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">the full list of top ranked stocks here.</a>
&nbsp;
Learn more about the <a href="https://www.zacks.com/education/stock-scorecard/value-trading">Value score and how it is calculated here.</a>
&nbsp;
<h2>Only $1 to See All Zacks&#39; Buys and Sells</h2>
We&#39;re not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like&nbsp;Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/6328?adid=SYND_BENZ_ZU_ZU_ZACKS1RANKADDITIONS_268_02112025_2413286&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286" style="font-weight:bold">See Stocks Now &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_268_2413286&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EZPW&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_EZPW&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">EZCORP, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PCRX&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_PCRX&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">Pacira BioSciences, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/pcrx#NASDAQ">PCRX</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=OMVKY&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_OMVKY&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">OMV AG (OMVKY): Free Stock Analysis Report</a>
<a href="https://www.zacks.com/commentary/2413286/best-value-stocks-to-buy-for-february-11th?cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Small Cap

PCRX

Best Value Stocks To Buy For February 11th

Canaccord Genuity analyst Brian McNamara maintains EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy and raises the price target from $19 to $22.

Canaccord Genuity Maintains Buy on EZCORP, Raises Price Target to $22

Press Releases

EZCORP Reports First Quarter Fiscal 2025 Results Record PLO Drives Strong Increase in Net Income

EZCORP to Host Annual Meeting of Stockholders on Thursday, March 13, 2025

EZCORP Announces Termination of Acquisition Agreement

EZCORP Announces Private Offering of $300,000,000 of Senior Notes Due 2032

EZCORP Announces Pricing of Private Offering of $300,000,000 of Senior Notes Due 2032

EZCORP Announces Closing of Private Offering of $300,000,000 of Senior Notes Due 2032

EZCORP to Release Second Quarter Fiscal 2025 Results After Market Close on Monday, April 28, 2025

EZCORP Reports Second Quarter Fiscal 2025 Results

EZCORP Announces Retirement of $103.4 Million Convertible Notes

Kanen Wealth Management Urges EZCORP (NASDAQ: EZPW) Board to Authorize Immediate Buyback Program

Antalpha Platform Holding Company - Ordinary Shares

Antalpha Platform Holding

Atlanticus Holdings Corporation - Common Stock

Atlanticus Holdings

Bread Financial Holdings, Inc. Common Stock

Bread Finl Hldgs

Consumer Portfolio Services, Inc. - Common Stock

Consumer Pf Servs

DeFi Development

Encore Capital Gr

Enova International

FinVolution Group American Depositary Shares

FinVolution Group

Green Dot Corporation Class A Common Stock, $0.001 par value

Green Dot

Jiayin Group Inc. - American Depositary Shares

Jiayin Gr

LendingClub

LexinFintech Holdings Ltd. - American Depositary Shares

LexinFintech Holdings

Medallion Financial

Navient

Nerdwallet

OppFi

Oportun Financial Corporation - common stock

Oportun Financial

PRA Group

PROG Holdings

Qudian Inc. American Depositary Shares, each representing one Class A Ordinary Share

Qudian

Regional Management

LendingTree

World Acceptance Corporation - Common Stock

World Acceptance

X Financial American Depositary Shares, each representing six Class A Ordinary Shares

X Financial

Yiren Digital Ltd. American Depositary Shares, each representing two ordinary shares

Comments

EZCORP

EZCORP (EZPW) Opzioni

EZCORP (NASDAQ:EZPW) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO